Study title:
Tomonari A,
Takahashi S, Ooi
J, Tsukada N,
Konuma T,
Kobayashi T,
Takasugi K, Iseki
T, Tojo A, Asano
S.Preemptive therapy with
ganciclovir 5 mg/kg once daily for
cytomegalovirus infection after
unrelated cord blood
transplantation. Bone Marrow
Transplant. 2008
Feb;41(4):371-6.Tomonari A,
Takahashi S, Ooi
J, Tsukada N,
Konuma T,
Kobayashi T,
Takasugi K, Iseki
T, Tojo A, Asano
S.Preemptive therapy with
ganciclovir 5 mg/kg once daily for
cytomegalovirus infection after
unrelated cord blood
transplantation. Bone Marrow
Transplant. 2008
Feb;41(4):371-6.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Tomonari A et al 2008.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
Y
|